Literature DB >> 9684868

Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide.

K S Lau1, R W Grange, W J Chang, K E Kamm, I Sarelius, J T Stull.   

Abstract

Nitric oxide generated by neuronal nitric oxide synthase in contracting skeletal muscle fibers may regulate vascular relaxation via a cGMP-mediated pathway. Neuronal nitric oxide synthase content is greatly reduced in skeletal muscles from mdx mice. cGMP formation increased in contracting extensor digitorum longus muscles in vitro from C57 control, but not mdx mice. The increase in cGMP content was abolished with NG-nitro-L-arginine. Sodium nitroprusside treatment increased cGMP levels in muscles from both C57 and mdx mice. Skeletal muscle contractions also inhibited phenylephrine-induced phosphorylation of smooth muscle myosin regulatory light chain. Arteriolar dilation was attenuated in contracting muscles from mdx but not C57 mice. NO generated in contracting skeletal muscle may contribute to vasodilation in response to exercise.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684868     DOI: 10.1016/s0014-5793(98)00728-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Swim training does not protect mice from skeletal muscle oxidative damage following a maximum exercise test.

Authors:  Tatiane Oliveira Barreto; Lorena Sabino Cleto; Carolina Rosa Gioda; Renata Sabino Silva; Ana Carolina Campi-Azevedo; Junia de Sousa-Franco; José Carlos de Magalhães; Claudia Lopes Penaforte; Kelerson Mauro de Castro Pinto; Jader dos Santos Cruz; Etel Rocha-Vieira
Journal:  Eur J Appl Physiol       Date:  2011-11-11       Impact factor: 3.078

2.  Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Cheryl Smith; Kevin Engels; Jean L Olson; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

3.  {alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle.

Authors:  David G Lambert; Gail D Thomas
Journal:  J Physiol       Date:  2004-12-23       Impact factor: 5.182

Review 4.  Control of muscle blood flow during exercise: local factors and integrative mechanisms.

Authors:  I Sarelius; U Pohl
Journal:  Acta Physiol (Oxf)       Date:  2010-03-26       Impact factor: 6.311

5.  The prolonged intake of L-arginine-L-aspartate reduces blood lactate accumulation and oxygen consumption during submaximal exercise.

Authors:  Martin Burtscher; Fritz Brunner; Martin Faulhaber; Barbara Hotter; Rudolf Likar
Journal:  J Sports Sci Med       Date:  2005-09-01       Impact factor: 2.988

6.  NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy.

Authors:  D S Bredt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Dystrophin-glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling.

Authors:  Joanne F Garbincius; Daniel E Michele
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

8.  Muscle contraction under capillaries in hamster muscle induces arteriolar dilatation via K(ATP) channels and nitric oxide.

Authors:  Kenneth D Cohen; Ingrid H Sarelius
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

9.  Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.

Authors:  Aaron Erdely; Laszlo Wagner; Veronica Muller; Attila Szabo; Chris Baylis
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

10.  Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.

Authors:  M Khairallah; R J Khairallah; M E Young; B G Allen; M A Gillis; G Danialou; C F Deschepper; B J Petrof; C Des Rosiers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.